Biogen Hires Pfizer Neuroscientist Michael Ehlers as R&D Chief

Biogen Inc. has hired Pfizer Inc.’s Michael Ehlers to be its new research and development chief, filling a vacancy at the biotechnology company that has been open for nine months. Ehlers, 47, will join Cambridge, Massachusetts-based Biogen in late May, the company said Wednesday in a statement. Ehlers was Pfizer’s group senior vice president for biotherapeutics R&D and chief scientific officer for the company’s neuroscience and pain research unit, which included work on programs in Alzheimer’s disease, Parkinson’s disease and schizophrenia. Before that, he was a neurobiology professor at Duke University Medical Center. “We scoured the globe, and we were committed to keeping the search going until we found a person who would be a great fit,” Biogen Chief Executive Officer George Scangos said in a phone interview. Ehlers is “not…


Link to Full Article: Biogen Hires Pfizer Neuroscientist Michael Ehlers as R&D Chief